Cargando…
Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
During the past decade, the efficacy of new molecular targeted drugs such as tyrosine kinase inhibitors (TKIs) and monoclonal antibodies has been proven worldwide, and molecular targeted therapies have become the mainstream in cancer therapy. However, clinical use of these new drugs presents unexpec...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385703/ https://www.ncbi.nlm.nih.gov/pubmed/25874259 http://dx.doi.org/10.1155/2015/842101 |